Birth Control Pills for PMS and PMDD: What They Can and Cannot Do

Birth control pills may help some people with premenstrual symptoms, but results vary. In the United States, Yaz, a combined pill containing drospirenone and ethinyl estradiol, has an FDA-approved indication for symptoms of premenstrual dysphoric disorder (PMDD) in people who also choose an oral contraceptive for birth control. That does not mean every pill treats PMDD, or that Yaz has been evaluated for treating ordinary premenstrual syndrome (PMS). Yaz prescribing information Office on Women's Health: PMDD

PMS and PMDD are not the same thing

The Office on Women's Health explains that PMS includes physical and emotional symptoms; hormonal birth control may ease some physical symptoms but can make other symptoms worse.

PMS can involve physical and emotional symptoms before a period, such as bloating, breast tenderness, irritability, or changes in sleep. PMDD involves more severe symptoms, particularly mood symptoms, that can significantly disrupt work, school, relationships, or daily life. Symptoms typically appear before a period and improve within a few days after bleeding begins. Office on Women's Health: symptoms and diagnosis

A difficult week every month deserves attention, even if you do not know which label applies. Depression, anxiety, and other conditions can also worsen around a period. A clinician may ask you to record symptoms daily across at least two cycles to assess the pattern and consider other explanations. You do not have to wait two months to ask for help, particularly if symptoms are severe. Yaz label: PMDD assessment

A record can support a clinical conversation; it cannot establish the diagnosis by itself. If your main question is whether symptoms began after starting or switching contraception, see our separate guide to mood changes on the pill.

Which birth control pills have a PMDD indication?

Yaz contains 3 mg drospirenone and 0.02 mg ethinyl estradiol in each active tablet. Its pack has 24 active pills followed by four inactive pills. Its US PMDD indication applies to people who have chosen an oral contraceptive for contraception. Yaz official label

Yaz is not the only brand with this indication. Beyaz also has a US PMDD indication for people choosing oral contraception. Its label includes drospirenone, ethinyl estradiol, and levomefolate calcium. This is not a recommendation to choose one product over another or to substitute products: check the exact label and discuss options with a prescriber or pharmacist. Beyaz official label

The exact product matters. A pill containing drospirenone alone is not the same formulation as a combined drospirenone and ethinyl estradiol pill. Nor does any pill automatically have Yaz's evidence or approved uses because it prevents pregnancy or shares an ingredient. Our Yaz reference page helps you locate the product's ingredients, pack details, and official source.

Other pills may be considered by clinicians outside a particular FDA-approved indication. That is a different statement from saying every combined pill is approved for PMDD or will improve an individual's symptoms.

What do the PMS and three-cycle limitations mean?

The Yaz label states that effectiveness for PMDD beyond three menstrual cycles has not been evaluated and that Yaz has not been evaluated for treating PMS. These are specific limits of the evidence described in its labeling. Yaz label: indications and limitations

The three-cycle statement is not an instruction to stop after three months. Do not turn it into a treatment deadline or a promise that symptoms will improve by then. Discuss ongoing symptoms, benefits, side effects, and whether to continue treatment with your prescriber.

Likewise, “not evaluated for PMS” does not mean the label proves that Yaz never helps anyone with PMS. It means the PMDD indication should not be presented as evidence of an approved PMS treatment.

Can a pill make mood symptoms worse?

Some people report mood changes. Yaz's prescribing information lists mood-related adverse reactions, and an individual's experience may differ from study averages. If symptoms worsened after starting or switching pills, tell your prescriber when the change began, which pill you take, how much it affects your life, and whether symptoms occur around bleeding or throughout the month. Yaz label: adverse reactions

Significant or worsening depression needs prompt medical attention. The Yaz label advises careful observation of people with a history of depression and discontinuation if depression recurs to a serious degree. Contact your prescriber promptly for directions about your medicine and contraception; do not assume you must keep taking it or wait several months despite serious symptoms. Yaz label: depression warning

If treatment changes, ask when your new contraceptive method becomes effective and whether backup is needed. Managing contraception should be part of the care plan, not a reason to delay urgent mental-health support. Our pill and mood research guide explains why population findings cannot predict one person's experience.

Is the pill the only PMDD treatment?

No. Treatment depends on symptoms, preferences, medical history, and whether you also want contraception. Options include selective serotonin reuptake inhibitors (SSRIs), hormonal treatments, psychological approaches, and care for physical symptoms. Some people benefit from more than one approach. Office on Women's Health: treatment ACOG clinical practice guideline: management of premenstrual disorders

Combined pills are not suitable for everyone. Your prescriber should review factors such as migraine history, smoking, clot risk, other conditions, and medicines before recommending an estrogen-containing pill. Yaz also has specific kidney, adrenal, liver, and potassium-related restrictions and warnings. This is not a complete eligibility checklist. Yaz label: contraindications and warnings

What should you track before an appointment?

A simple daily record can make the conversation more useful. Include the easier days as well as the difficult ones so your clinician can assess timing, not just severity. Office on Women's Health: keeping a symptom record

• Your mood symptoms and how much they interfere with daily life.
• Physical symptoms, such as cramps, headaches, or breast tenderness.
• When symptoms begin and improve, and when bleeding occurs.
• Your pill name, pack schedule, and any recent start or switch.
• Missed pills, other medicines, or changes to your routine that you want to discuss.

If your clinician recommends a particular daily rating form, use it as directed. A general app record is not a substitute for a diagnostic assessment.